Cite
HARVARD Citation
Tanaka, Y. et al. (n.d.). SAT0193 A PHASE 3, OPEN-LABEL, CONTINUATION STUDY EVALUATING LONG-TERM SAFETY AND EFFICACY OF BELIMUMAB IN PATIENTS FROM JAPAN AND KOREA WITH SYSTEMIC LUPUS ERYTHEMATOSUS, FOR UP TO 7 YEARS. Annals of the rheumatic diseases. pp. 1038-1039. [Online].